Validation of LENT and PROMISE scores in malignant pleural effusion in an Asian population

C. Wong (Hong Kong, Hong Kong), W. Wong (Hong Kong, Hong Kong), K. So (Hong Kong, Hong Kong), Y. Yam (Hong Kong, Hong Kong)

Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Wong (Hong Kong, Hong Kong), W. Wong (Hong Kong, Hong Kong), K. So (Hong Kong, Hong Kong), Y. Yam (Hong Kong, Hong Kong). Validation of LENT and PROMISE scores in malignant pleural effusion in an Asian population. 4491

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The survival prediction of malignant pleural effusion and the validation of LENT prognosis score in Thai patients.
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019


Malignant pleural effusion survival prognostication in an Asian population
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Year: 2019



A Dutch web-survey on management of malignant pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011


Malignant pleural mesothelioma in our material: evaluation by EORTC prognostic scoring system
Source: Eur Respir J 2001; 18: Suppl. 33, 396s
Year: 2001

The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion
Source: Eur Respir J, 55 (5) 1900980; 10.1183/13993003.00980-2019
Year: 2020



Lent score validation on patients with malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Contribution of PIPE Score on prognostic evaluation of idiopathic pleural effusions (IPE)
Source: International Congress 2016 – Pleural diseases
Year: 2016


Late Breaking Abstract - Prognostic and therapeutic markers of malignant pleural effusion – The PROMISE study
Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside
Year: 2017



Modified Glasgow Prognostic Score – a predictor of survival in malignant pleural effusion
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021


Heterogeneous delivery of definitive interventions in malignant pleural effusions – results from a Danish survey.
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019


Does the sonographic presence and severity of pleural fluid septation have an impact on clinical outcomes in pleural infection? - Data from the Pleural Infection Longitudinal Outcome Study (PILOT)
Source: International Congress 2018 – New methods for diagnosing and treating lung diseases
Year: 2018



Malignant pleural effusion: different treatments through countries
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


Evaluation of patients with pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 247s
Year: 2004

Impact of sarcopenia in long-term symptoms in patients with malignant pleural effusion.
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021


Risk stratifying pleural infection using RAPID score in an Asian population
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021


Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Tool methods in the diagnosis of pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 628s
Year: 2004